The inflammophilic character of the periodontitis-associated microbiota

Mol Oral Microbiol. 2014 Dec;29(6):248-57. doi: 10.1111/omi.12065. Epub 2014 Sep 8.


In periodontitis, dysbiotic microbial communities exhibit synergistic interactions for enhanced protection from host defenses, nutrient acquisition, and persistence in an inflammatory environment. This review discusses evidence that periodontitis-associated communities are 'inflammo-philic' (=loving or attracted to inflammation) in that they have evolved to not only endure inflammation but also to take advantage of it. In this regard, inflammation can drive the selection and enrichment of these pathogenic communities by providing a source of nutrients in the form of tissue breakdown products (e.g. degraded collagen peptides and heme-containing compounds). In contrast, those species that cannot benefit from the altered ecological conditions of the inflammatory environment, or for which host inflammation is detrimental, are likely to be outcompeted. Consistent with the concept that inflammation fosters the growth of dysbiotic microbial communities, the bacterial biomass of human periodontitis-associated biofilms was shown to increase with increasing periodontal inflammation. Conversely, anti-inflammatory treatments in animal models of periodontitis were shown to diminish the periodontal bacterial load, in addition to protecting from bone loss. The selective flourishing of inflammophilic bacteria can perpetuate inflammatory tissue destruction by setting off a 'vicious cycle' for disease progression, in which dysbiosis and inflammation reinforce each other. Therefore, the control of inflammation appears to be central to the treatment of periodontitis, as it is likely to control both dysbiosis and disease progression.

Keywords: P. gingivalis; Toll-like receptors; dysbiosis; inflammation; periodontitis.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Alveolar Bone Loss / etiology
  • Animals
  • Anti-Inflammatory Agents / therapeutic use
  • Bacterial Load
  • Biofilms
  • Disease Models, Animal
  • Disease Progression
  • Dysbiosis* / immunology
  • Host-Pathogen Interactions
  • Humans
  • Inflammation* / microbiology
  • Microbiota* / immunology
  • Periodontitis / immunology*
  • Periodontitis / microbiology*
  • Periodontitis / therapy
  • Porphyromonas gingivalis / immunology


  • Anti-Inflammatory Agents